• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

花生四烯酸激活肿瘤内甾体合成在前列腺癌向去势抵抗性进展过程中。

Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance.

机构信息

Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.

出版信息

Prostate. 2010 Feb 15;70(3):239-51. doi: 10.1002/pros.21057.

DOI:10.1002/pros.21057
PMID:19790237
Abstract

BACKGROUND

De novo androgen synthesis and subsequent androgen receptor (AR) activation has recently been shown to contribute to castration-resistant prostate cancer (CRPC) progression. Herein we provide evidence that fatty acids (FA) can trigger androgen synthesis within steroid starved prostate cancer (CaP) tumor cells.

METHODS

Tumoral FA and steroid levels were assessed by GC-MS and LC-MS, respectively. Profiles of genes and proteins involved in FA activation of steroidogenesis were assessed by fluorescence microscopy, immunohistochemistry, microarray expression profiling and Western blot analysis.

RESULTS

In human CaP tissues the levels of proteins responsible for FA activation of steroid synthesis were observed to be altered during progression to CRPC. Further investigating this mechanism in LNCaP cells, we demonstrate that specific FA, arachidonic acid, is synthesized in an androgen-dependent and AR-mediated manner. Arachidonic acid is known to induce steroidogenic acute regulatory protein (StAR) in steroidogenic cells. When bound to hormone sensitive lipase (HSL), StAR shuttles free cholesterol into the mitochondria for downstream conversion into androgens. We show that arachidonic acid induces androgen production in steroid starved LNCaP cells coincidently in the same conditions that HSL and StAR are predominantly localized in the mitochondria. Furthermore, their activities are verified by a functional increase in mitochondrial uptake of cholesterol in this steroid starved environment.

CONCLUSIONS

We propose that this characterized arachidonic acid induced steroidogenesis mechanism significantly contributes to the activation of AR in CRPC progression and therefore recommend that fatty acid pathways be targeted therapeutically in progressing CaP.

摘要

背景

新的雄激素合成和随后的雄激素受体 (AR) 激活最近被证明有助于去势抵抗性前列腺癌 (CRPC) 的进展。在此,我们提供了证据表明脂肪酸 (FA) 可以在类固醇饥饿的前列腺癌 (CaP) 肿瘤细胞内触发雄激素合成。

方法

通过 GC-MS 和 LC-MS 分别评估肿瘤中的 FA 和类固醇水平。通过荧光显微镜、免疫组织化学、微阵列表达谱分析和 Western blot 分析评估参与 FA 激活类固醇生成的基因和蛋白质谱。

结果

在人 CaP 组织中,观察到负责 FA 激活类固醇合成的蛋白质水平在向 CRPC 进展过程中发生改变。在 LNCaP 细胞中进一步研究这种机制,我们证明特定的 FA,花生四烯酸,以雄激素依赖和 AR 介导的方式合成。花生四烯酸已知在类固醇生成细胞中诱导类固醇生成急性调节蛋白 (StAR)。当与激素敏感脂肪酶 (HSL) 结合时,StAR 将游离胆固醇穿梭到线粒体中,用于下游转化为雄激素。我们表明,花生四烯酸在类固醇饥饿的 LNCaP 细胞中诱导雄激素产生,与 HSL 和 StAR 主要定位于线粒体的条件相同。此外,在这种类固醇饥饿的环境中,通过功能性增加线粒体摄取胆固醇来验证它们的活性。

结论

我们提出,这种特征化的花生四烯酸诱导的类固醇生成机制极大地促进了 AR 在 CRPC 进展中的激活,因此建议在进展性 CaP 中针对脂肪酸途径进行治疗。

相似文献

1
Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance.花生四烯酸激活肿瘤内甾体合成在前列腺癌向去势抵抗性进展过程中。
Prostate. 2010 Feb 15;70(3):239-51. doi: 10.1002/pros.21057.
2
Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model.胆固醇调节的改变有助于在小鼠异种移植模型中向去势抵抗性前列腺癌进展过程中产生肿瘤内雄激素。
Prostate. 2010 Mar 1;70(4):390-400. doi: 10.1002/pros.21072.
3
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.在去势抵抗性前列腺癌进展过程中,雄激素水平通过肿瘤内从头类固醇生成而升高。
Cancer Res. 2008 Aug 1;68(15):6407-15. doi: 10.1158/0008-5472.CAN-07-5997.
4
Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.前列腺癌激素治疗的关键靶点。第1部分:雄激素受体和类固醇生成途径。
BJU Int. 2009 Aug;104(4):438-48. doi: 10.1111/j.1464-410X.2009.08695.x. Epub 2009 Jun 24.
5
Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.雄激素受体依赖性Bcl-xL表达调控:对前列腺癌进展的影响。
Prostate. 2008 Mar 1;68(4):453-61. doi: 10.1002/pros.20723.
6
New agents and strategies for the hormonal treatment of castration-resistant prostate cancer.用于去势抵抗性前列腺癌的激素治疗的新药物和新策略。
Expert Opin Investig Drugs. 2010 Jul;19(7):837-46. doi: 10.1517/13543784.2010.494178.
7
Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.前列腺癌中β2 - 肾上腺素能受体水平的激素调节
Prostate. 2008 Jul 1;68(10):1133-42. doi: 10.1002/pros.20778.
8
Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.前列腺癌细胞通过增加核雄激素受体和雄激素受体共激活因子来提高雄激素敏感性;这可能是前列腺癌细胞激素抵抗的一种机制。
Cancer Invest. 2007 Feb;25(1):32-7. doi: 10.1080/07357900601130698.
9
Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model.利用新型异种移植模型鉴定 EP4 作为治疗去势抵抗性前列腺癌的潜在靶点。
Cancer Res. 2010 Feb 15;70(4):1606-15. doi: 10.1158/0008-5472.CAN-09-2984. Epub 2010 Feb 9.
10
Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells.类固醇激素对CWR22Rv1人前列腺癌细胞中生长、前列腺特异性抗原分泌以及由突变雄激素受体介导的转录的调节作用。
Mol Cell Endocrinol. 2004 Jul 30;222(1-2):121-32. doi: 10.1016/j.mce.2004.04.013.

引用本文的文献

1
New insights into lipid metabolism and prostate cancer (Review).脂质代谢与前列腺癌的新认识(综述)。
Int J Oncol. 2023 Jun;62(6). doi: 10.3892/ijo.2023.5522. Epub 2023 May 19.
2
Caprylic Acid (FFA C8:0) promotes the progression of prostate cancer by up-regulating G protein-coupled receptor 84/ Krüppel-like factor 7.辛酸(FFA C8:0)通过上调 G 蛋白偶联受体 84/ 类 Krüppel 因子 7 促进前列腺癌的进展。
BMC Cancer. 2023 May 11;23(1):426. doi: 10.1186/s12885-023-10841-2.
3
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models.
强效 AMPK 抑制剂 BAY-3827 在雄激素依赖性前列腺癌模型中显示出强大的疗效。
Cell Oncol (Dordr). 2021 Jun;44(3):581-594. doi: 10.1007/s13402-020-00584-8. Epub 2021 Jan 25.
4
Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer.治疗诱导的脂质摄取和重塑是前列腺癌铁死亡超敏反应的基础。
Cancer Metab. 2020 Jun 19;8:11. doi: 10.1186/s40170-020-00217-6. eCollection 2020.
5
Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy.胰岛素样生长因子受体信号在肿瘤发生和耐药中的作用:癌症治疗的挑战。
J Hematol Oncol. 2020 Jun 3;13(1):64. doi: 10.1186/s13045-020-00904-3.
6
Metabolic Alterations, Aggressive Hormone-Naïve Prostate Cancer and Cardiovascular Disease: A Complex Relationship.代谢改变、侵袭性激素非依赖型前列腺癌与心血管疾病:一种复杂的关系。
Medicina (Kaunas). 2019 Mar 7;55(3):62. doi: 10.3390/medicina55030062.
7
Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer.去势抵抗性前列腺癌进展机制与治疗的最新进展
Onco Targets Ther. 2018 May 28;11:3167-3178. doi: 10.2147/OTT.S159777. eCollection 2018.
8
A brief history of intracrine androgen metabolism by castration-recurrent prostate cancer.去势抵抗性前列腺癌的内分泌雄激素代谢简史
Am J Clin Exp Urol. 2018 Apr 1;6(2):101-106. eCollection 2018.
9
An intracrine view of sex steroids, immunity, and metabolic regulation.性激素、免疫和代谢调节的内分泌观点。
Mol Metab. 2018 Sep;15:92-103. doi: 10.1016/j.molmet.2018.03.001. Epub 2018 Mar 8.
10
ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells.ACSL3促进前列腺癌细胞内的肿瘤内类固醇生成。
Cancer Sci. 2017 Oct;108(10):2011-2021. doi: 10.1111/cas.13339. Epub 2017 Sep 10.